Assessing Paragon 28: Insights From 5 Financial Analysts

During the last three months, 5 analysts shared their evaluations of Paragon 28 FNA, revealing diverse outlooks from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a high estimate of $15.00, and a low estimate of $13.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.47%.

Exploring Analyst Ratings: An In-Depth Overview

A comprehensive examination of how financial experts perceive Paragon 28 is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Paragon 28. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Paragon 28 compared to the broader market.
• Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Paragon 28's stock. This comparison reveals trends in analysts' expectations over time.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Paragon 28's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Paragon 28 analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Unveiling the Story Behind Paragon 28

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

Paragon 28: Financial Performance Dissected

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Over the 3 months period, Paragon 28 showcased positive performance, achieving a revenue growth rate of 18.1% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Paragon 28's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -19.79%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Paragon 28's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -8.62%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Paragon 28's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -4.03%, the company may face hurdles in generating optimal returns from its assets.

Debt Management: Paragon 28's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.79, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Analyst Ratings: Simplified

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.